Status:
COMPLETED
Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy Subjects
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Depression
Depressive Disorder
Eligibility:
All Genders
18-55 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the effects of multiple doses of DVS SR and duloxetine on the pharmacokinetics of a single dose of desipramine in healthy subjects.
Eligibility Criteria
Inclusion
- Healthy men and women between 18 to 55 years of age.
- Healthy as determined by the investigator on the basis of medical history and physical examination, laboratory test results, vital signs and a 12-lead electrocardiogram.
- History of being a nonsmoker for a least 1 year.
Exclusion
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2006
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00366652
Start Date
September 1 2006
End Date
September 1 2006
Last Update
May 28 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neptune City, New Jersey, United States, 07753